Reuters logo
BRIEF-Shionogi and Purdue Pharma announce U.S availability of Symproic (naldemedine)
October 12, 2017 / 12:42 PM / 2 months ago

BRIEF-Shionogi and Purdue Pharma announce U.S availability of Symproic (naldemedine)

Oct 12 (Reuters) - Shionogi & Co Ltd:

* Shionogi inc - co, Purdue Pharma L.P. announce that Symproic (naldemedine) 0.2 mg tablets are now available throughout United States​

* Shionogi - FDA ‍approved Symproic as once-daily oral tablet for treatment of opioid-induced constipation in adult patients with chronic non-cancer pain​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below